Neumora Therapeutics Inc....

1.06
-0.04 (-3.64%)
At close: Mar 28, 2025, 2:02 PM

Neumora Therapeutics Common Stock Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -6.93 -11.48 -18.86 -10.4 -24.87 n/a
PEG Ratio -2.58 -0.16 0.42 -0.07 n/a n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 5.89 5.77 -5.53 -7.59 -26.16 n/a
P/FCF Ratio -9.23 -16.57 -21.4 -32.39 -88 n/a
P/OCF Ratio -9.23 -16.59 -21.49 -32.74 -92.27 n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.01 -0.02 -0.01 -0.02 n/a
Quick Ratio 10.51 19.05 16.37 17.85 20.69 n/a
Current Ratio 10.51 19.05 16.37 17.85 20.69 n/a
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.85 -0.5 0.29 0.73 1.05 n/a
Return on Assets (ROA) -0.77 -0.48 -0.31 -0.55 -0.5 n/a
Return on Capital (ROIC) -0.92 -0.4 -0.34 -0.58 -0.51 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a